Biblio

Author Title [ Type

] Year

Filters: Author is Turhan, Ali G [Clear All Filters]

Journal Article

Gentil M, Hugues P, Desterke C, Telliam G, Sloma I, Souza LEB, Baykal S, Artus J, Griscelli F, Guerci A, et al. Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML). PLoS One. 2018;13(8):e0200923.

Chaker D, Desterke C, Moniaux N, Bani M-A, Oudrhiri N, Faivre J, Turhan AG, Bennaceur-Griscelli A, Griscelli F. Direct reprogramming of hepatocytes into JAK/Stat-dependent LGR5+ liver cells able to initiate intrahepatic cholangiocarcinoma. Stem Cells. 2024.

Baykal-Köse S, Voldoire M, Desterke C, Sorel N, Cayssials E, Johnson-Ansah H, Guerci-Bresler A, Bennaceur-Griscelli A, Chomel J-C, Turhan AG. ENOX2 NADH Oxidase: A BCR-ABL1-dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia (CML). Turk J Haematol. 2023.

Larbi A, Mitjavila-Garcia MTeresa, Flamant S, Valogne Y, Clay D, Usunier B, l'Homme B, Féraud O, Casal I, Gobbo E, et al. Generation of multipotent early lymphoid progenitors from human embryonic stem cells. Stem Cells Dev. 2014.

Marcoux P, Imeri J, Desterke C, Latsis T, Chaker D, Hugues P, Griscelli ABennaceur, Turhan AG. Impact of the overexpression of the tyrosine kinase receptor (RET) in the hematopoietic potential of induced pluripotent stem cells (iPSCs). Cytotherapy. 2023.

Turhan AG, Hwang JW, Chaker D, Tasteyre A, Latsis T, Griscelli F, Desterke C, Bennaceur-Griscelli A. iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology. Front Med (Lausanne). 2021;8:728543.

Hwang JWook, Loisel-Duwattez J, Desterke C, Latsis T, Pagliaro S, Griscelli F, Bennaceur-Griscelli A, Turhan AG. A novel neuronal organoid model mimicking glioblastoma (GBM) features from induced pluripotent stem cells (iPSC). Biochim Biophys Acta Gen Subj. 2020:129540.